Wacker Chemie AGReported 7% sales growth and raised full-year EBITDA guidance, driven by cost savings from PACE program.

Wacker Chemie AG reported a 7% year-over-year increase in group sales to 1.52 billion euros in the second quarter of 2026, while raising its full-year EBITDA guidance to a range of 625 million to 750 million euros. EBITDA before special pension effects rose 53% to 175 million euros, driven by cost savings from the PACE program, which contributed 45 million euros in the quarter and 85 million euros in the first half. Reported EBITDA reached 211 million euros, including a 37 million euro non-cash pension effect, and net income was 350 million euros, boosted by approximately 243 million euros in non-operating Siltronic-related effects. By segment, silicones sales grew 6% to 757 million euros with EBITDA of 123 million euros, polymers sales increased 12% to about 406 million euros with EBITDA of 69 million euros, biosolutions sales rose 13% to 99 million euros with EBITDA of 7 million euros, and polysilicon sales edged up 3% to roughly 226 million euros with EBITDA of 11 million euros. The company highlighted strong semiconductor-grade polysilicon volume growth of 10% in the first half, while noting subdued demand in construction and industrial markets, ongoing weakness in solar polysilicon, and a 90 million euro headwind from lower CO2 compensation.
Wacker Chemie AGReported 7% sales growth and raised full-year EBITDA guidance, driven by cost savings from PACE program.
Siltronic AG